SAB Biotherapeutics, Inc. - Common Stock (NQ:SABS)

3.070 +0.280 (+10.04%)

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SAB Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

SAB Biotherapeutics: Q1 Earnings Insights ↗

May 16, 2023

Via Benzinga

SAB Biotherapeutics Provides Company Update for Q1 2023 Financial Results

May 16, 2023

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

SAB Biotherapeutics Announces First Publication of Promising Nonclinical Data for SAB-183 Against Pneumonic Plague in the Journal Antibodies

May 12, 2023

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

SAB Biotherapeutics Announces Progress on U.S. FDA’s Phased Review of Company’s Groundbreaking DiversitAb™ Platform

May 09, 2023

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 04, 2023

Via Benzinga

SAB Biotherapeutics Presents Positive Phase 1 and 2a Data for SAB-176 Influenza Immunotherapy at ISIRV-AVG Conference

May 04, 2023

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials ↗

May 04, 2023

SAB Biotherapeutics Inc (NASDAQ: SABS) has announced the presentation of safety and efficacy data from Phase 1 and 2a trials of its influenza immunotherapy, SAB-176.

Via Benzinga

SAB Biotherapeutics to Present at Sidoti Virtual Investor Conference, May 10-11

May 03, 2023

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

SAB Biotherapeutics Announces Positive Results from Phase 3 Trial of SAB-185 in Patients with COVID-19 at High-Risk for Severe Complications

April 26, 2023

SAB-185, a human IgG1 (polyclonal) antibody therapeutic candidate, demonstrated benefit in sustained symptom resolution in patients with Omicron variants of SARS-CoV-2

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial ↗

April 26, 2023

SAB Biotherapeutics Inc (NASDAQ: SABS) has revealed topline results from the Phase 3 National Institutes of Health's (NIH) ACTIV-2 trial that assessed SAB-185 in non-hospitalized COVID-19 patients at...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket ↗

April 19, 2023

Gainers Clearmind Medicine Inc. (NASDAQ: CMND) jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced...

Via Benzinga

SAB Biotherapeutics Gets FDA Breakthrough Therapy Status On Influenza Treatment Candidate, Analysts Maintain Bullish Pitch ↗

April 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 18, 2023

Via Benzinga

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

Dow Dips Over 100 Points; Bank of America Earnings Beat Estimates ↗

April 18, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.42% to 33,842.93 while the NASDAQ fell 0.10% to 12,146.16. The S&P 500,...

Via Benzinga

Short Volatility Alert: Sab Biotherapeutics ↗

April 18, 2023

On Monday, shares of Sab Biotherapeutics (NASDAQ: SABS) experienced volatile short activity. After the activity, the stock price went up +6.13% to $0.77. The overall sentiment for SABS has been...

Via Benzinga

SAB Biotherapeutics Announces U.S. FDA Grants Breakthrough Therapy Designation to SAB-176 Influenza Immunotherapy

April 18, 2023

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

EXCLUSIVE: SAB Biotherapeutics Secures FDA Breakthrough Therapy Tag For Its Influenza Immunotherapy ↗

April 18, 2023

The FDA has granted Breakthrough Therapy Designation (BTD) to SAB Biotherapeutics Inc's (NASDAQ: SABS) SAB-176, an investigational therapy for post-exposure prophylaxis for Type A and Type B influenza...

Via Benzinga

Promising Upsides on these Biotech Penny Stocks

April 18, 2023

These three biotech stocks each have a consensus Buy rating. While they are down from historic highs, impressive upsides make them worth consideration.

Via MarketBeat

Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 14, 2023

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 14, 2023

Via Benzinga

Why Navidea Biopharmaceuticals Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket ↗

April 14, 2023

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 318% to $29.80 in pre-market trading after gaining more than 345% on Thursday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 14, 2023

It's time for another dive into the biggest pre-market stock movers with all the latest news traders need to know about for Friday!

Via InvestorPlace

Nasdaq Rises 2%; Consolidated Communications Shares Spike Higher ↗

April 13, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Thursday. The Dow traded up 1.09% to 34,013.93 while the NASDAQ rose 2% to 12,167. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 13, 2023

Via Benzinga

Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 13, 2023

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.

Via Benzinga

Dow Rises Over 100 Points; Delta Air Lines Earnings Miss Views ↗

April 13, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Thursday. The Dow traded up 0.43% to 33,790.58 while the NASDAQ rose 1.36% to 12,091.38. The S&P...

Via Benzinga

Why Is SAB Therapeutics Stock Trading Higher Today? ↗

April 13, 2023

SAB Therapeutics (NASDAQ: SABS) shares are trading higher on Thursday after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.